Table 3.
Outcome variables of ginger and placebo groups with control of baseline and other variables*
| Variables | B | 95% CI | P |
|---|---|---|---|
| Weight | -3.75 | (-5.20, -2.30) | < 0.001 |
| BMI | -1.25 | (-1.77, -0.72) | < 0.001 |
| FBS | -20.47 | (-38.19, -2.75) | 0.024 |
| Cholesterol | 5.32 | (-8.55, 19.19) | 0.445 |
| HDL | 0.07 | (-2.60, 2.75) | 0.957 |
| LDL | -0.60 | (-13.36, 12.16) | 0.925 |
| VLDL | 0.94 | (-7.72, 9.59) | 0.829 |
| TG | 1.44 | (-43.62, 46.51) | 0.949 |
| Lp(a) | -4.21 | (-8.16, -0.25) | 0.038 |
| CRP | -0.39 | (-0.79, 0.01) | 0.053 |
| TAC | -0.06 | (-0.18, 0.06) | 0.255 |
*
The model includes age, smoking, hypertension (HTN), and diabetes (Multiple linear regression test)
BMI: Body mass index; FBS: Fasting blood sugar; HDL: High-density lipoprotein; LDL: Low-density lipoprotein; VLDL: Very-low-density lipoprotein; TG: Triglyceride; Lp(a): Lipoprotein (a); CRP: C-reactive protein; TAC: Total antioxidant capacity; CI: Confidence interval